Saturday, December 3, 2022
Arabic Arabic Bengali Bengali English English French French Hindi Hindi Indonesian Indonesian Malay Malay Punjabi Punjabi Russian Russian Spanish Spanish Turkish Turkish Urdu Urdu

Covid-19: India approves Cadila’s 3-dose needle-free vaccine – News

Must Read

Queens Together- Top Ten Lease Highlights

Do you know these top ten lease highlights? A QEDC business consultation can help. This list is not legal...

London-based V7, which offers an API for data annotation and labeling needed for AI training models, raised a $33M Series A led by Radical...

Ingrid Lunden / TechCrunch: London-based V7, which offers an API for data annotation and labeling needed for AI...

No Kiara Advani-Sidharth Malhotra Wedding In January, Reveals Close Friend | Hindi Movie News

Of late, a section of the entertainment media has been jumping on the sofa with wedding plans for...



Cadila’s vaccine will be the second home-grown shot to get emergency approval in India.

The Indian drug regulator’s subject expert committee has recommended emergency use approval for Zydus Cadila’s three-dose Covid-19 vaccine, CNBC-TV18 reported on Friday, citing sources.

The committee added that Zydus needs to submit additional data for the 2-dose regimen of its vaccine, CNBC-TV18 said in a tweet.

The generic drugmaker, listed as Cadila Healthcare Ltd, applied for the authorisation of the vaccine ZyCoV-D on July 1, based on an efficacy rate of 66.6 per cent in a late-stage trial of more than 28,000 volunteers nationwide.

If approved, Zydus Cadila’s vaccine will be the second home-grown shot to get emergency authorisation in India after Bharat Biotech’s Covaxin.

Zydus Cadila and India’s drug regulator did not immediately respond to a Reuters request for comment.




- Advertisement -
- Advertisement -

Latest News

Queens Together- Top Ten Lease Highlights

Do you know these top ten lease highlights? A QEDC business consultation can help. This list is not legal...
- Advertisement -

More Articles Like This

- Advertisement -